Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies999
Vertex Pharmaceuticals
Vertex is a global biotech company creating transformative medicines for serious diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a leading company in the field of RNA-targeted therapeutics.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
Conatus Pharmaceuticals
Conatus Pharmaceuticals is a biotechnology company focused on developing and commercializing innovative medicines to treat chronic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Dyax
Dyax Corp. is a biopharmaceutical company that develops and commercializes biotherapeutics for unmet medical needs.
Sector
Subsector
Keywords
Location
M&A Details1
Transaction name
Acquired by
Teva Pharmaceutical Industries
announced date
price
Financials
Investments6
SymBio Pharmaceuticals
SymBio Pharmaceuticals creates therapeutic products for cancer, hematology, and autoimmune diseases.
Sector
Subsector
Location
total rounds
total raised
SymBio Pharmaceuticals
SymBio Pharmaceuticals creates therapeutic products for cancer, hematology, and autoimmune diseases.
Sector
Subsector
Location
total rounds
total raised
SymBio Pharmaceuticals
SymBio Pharmaceuticals creates therapeutic products for cancer, hematology, and autoimmune diseases.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
Acquisitions6
ChemGenex Pharmaceuticals acquired by Cephalon
acquirer
date
type
price
ChemGenex Pharmaceuticals
ChemGenex Pharmaceuticals is an integrated biopharmaceutical development company focused on discovering and developing oncology drugs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Gemin X Pharmaceuticals acquired by Cephalon
acquirer
date
type
price
Gemin X Pharmaceuticals
Gemin X Pharmaceuticals develops targeted cancer therapeutics to improve patients' lives.
Sector
Subsector
Location
total rounds
total raised
Ception Therapeutics acquired by Cephalon
acquirer
date
type
price
Ception Therapeutics
Ception Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders1
Noubar Afeyan
Noubar Afeyan is Founder, Senior Managing Partner and Chief Executive Officer at Flagship Ventures, a leading early stage venture capital firm. Noubar also leads the firm's VentureLabs unit that invents and launches transformative startups. Noubar is a Senior Lecturer at MIT’s Sloan School of Management where he has taught courses on technology-entrepreneurship, innovation and leadership since 2000. Noubar lectures widely in the United States and internationally on diverse topics ranging from entrepreneurship, innovation and venture capital to biological engineering, drug discovery, medical technologies and renewable energy. During his 28-year career as inventor, entrepreneur, CEO and venture capitalist, Noubar has co-founded and helped build over 35 successful life science and technology startups. Noubar was Founder and Chief Executive Officer at PerSeptive Biosystems, a leader in the bio-instrumentation field that grew to over $100M in annual sales within six years from its first sales. After PerSeptive's acquisition by Perkin Elmer/Applera Corporation in 1998, Noubar was Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics. Currently Noubar serves on a number of public and private company boards including CiBO Technologies, Epiva BioSciences, Evelo BioSciences, Joule Unlimited, Kaleido BioSciences, Moderna Therapeutics, Pronutria Biosciences and Seres Therapeutics. Previously, Noubar was a Member of the founding team, Director and Investor in several highly successful ventures including Chemgenics Pharmaceuticals (acquired by Millennium Pharmaceuticals), Color Kinetics (acquired by Philips), Adnexus Therapeutics (acquired by Bristol-Myers Squibb) and Affinnova (acquired by AC Nielsen). Noubar received a Technology Pioneer 2012 award from the World Economic Forum in recognition of the breakthrough solar fuel technology being developed at Joule Unlimited. Noubar has served as Chairman of the Global Agenda Council on Chemicals, Advanced Materials and Biotechnology of the World Economic Forum as well as being a member of the Meta-Council on Emerging Technologies. Noubar is a Member of the Board of Overseers of the Boston Symphony Orchestra. In addition, he serves on the board of AmeriaBank and of UWC Dilijan International School, both of Armenia. Previously, Noubar was a Co-Founder and Member of the Board of Directors at National Competitiveness Foundation of Armenia, a private-public partnership dedicated to promoting economic development in the former Soviet Republic of Armenia. In 2008 Noubar received the Ellis Island Medal of Honor, an award granted to outstanding Americans who have distinguished themselves as United States citizens and who have enabled their ancestry groups to maintain their identities while becoming integral parts of American life. Noubar has authored numerous scientific publications and patents since earning his Ph.D. in Biochemical Engineering from MIT in 1987. Cygnal is a best-in-class team of biomedical experts and leaders collaborating to revolutionize how the world treats diseases.
current job
organization founded
Noubar Afeyan
Employee Profiles11
H. Jeffrey Wilkins
Vice President of Worldwide Clinical Development: Oncology and Immunology
Chris Rivera
Sales, Marketing, Commercial Operations and Management